Bicara Therapeutics Inc (NASDAQ: BCAX) kicked off on Monday, down -4.85% from the previous trading day, before settling in for the closing price of $14.64. Over the past 52 weeks, BCAX has traded in a range of $7.80-$24.70.
While this was happening, its average annual earnings per share was recorded 38.24%. With a float of $30.99 million, this company’s outstanding shares have now reached $54.61 million.
Bicara Therapeutics Inc (BCAX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Bicara Therapeutics Inc is 43.26%, while institutional ownership is 63.90%. The most recent insider transaction that took place on Oct 15 ’25, was worth 226,942. In this transaction President and COO of this company sold 12,500 shares at a rate of $18.16, taking the stock ownership to the 198,141 shares. Before that another transaction happened on Oct 16 ’25, when Company’s Officer proposed sale 24,103 for $18.83, making the entire transaction worth $453,761.
Bicara Therapeutics Inc (BCAX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.39 earnings per share (EPS), lower than consensus estimate (set at -0.28) by -0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
Bicara Therapeutics Inc (NASDAQ: BCAX) Trading Performance Indicators
Take a look at Bicara Therapeutics Inc’s (BCAX) current performance indicators. Last quarter, stock had a quick ratio of 25.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.23, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of Bicara Therapeutics Inc (BCAX)
Bicara Therapeutics Inc (NASDAQ: BCAX) saw its 5-day average volume 0.76 million, a positive change from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 13.95%.
During the past 100 days, Bicara Therapeutics Inc’s (BCAX) raw stochastic average was set at 48.53%, which indicates a significant increase from 4.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.15 in the past 14 days, which was higher than the 0.86 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.69, while its 200-day Moving Average is $12.67. Nevertheless, the first resistance level for the watch stands at $14.89 in the near term. At $15.86, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.43. If the price goes on to break the first support level at $13.35, it is likely to go to the next support level at $12.78. The third support level lies at $11.81 if the price breaches the second support level.
Bicara Therapeutics Inc (NASDAQ: BCAX) Key Stats
The company with the Market Capitalisation of 760.75 million has total of 54,612K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -68,000 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -27,390 K.
